This publication is a summary of a recent presentation by Dr Laurie Sehn, Clinical Assistant Professor
with the British Columbia Cancer Agency and University of British Columbia, Canada. She spoke to
medical oncologists, haematologists and oncology registrars in Auckland in October 2010, about
rituximab maintenance therapy in indolent non-Hodgkin’s lymphoma.
Download PDF